Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00406952 · ClinicalTrials.gov registry record · NA

Study for Evaluating Different Methods of Measuring Depression Treatment Response

A NA study, sponsored by Pfizer.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT00406952: Completed NA study, sponsored by Pfizer.

NCT00406952 is a NA study that has completed, run by Pfizer. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00406952, a NA study, has completed, sponsored by Pfizer.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.

Interventions

  • DRUG Placebo
  • DRUG Sertraline
  • PROCEDURE electronic diary
  • PROCEDURE voice acoustics

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2006-11
Est. Completion 2007-08
Phase NA
Pfizer

1,845 total trials

What the finished NCT00406952 record still lists

NCT00406952 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT00406952 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00406952 about?

NCT00406952 is a clinical study titled "Study for Evaluating Different Methods of Measuring Depression Treatment Response". Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.

What is the current status of trial NCT00406952?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2006-11. Estimated completion is 2007-08.

What interventions are being tested in trial NCT00406952?

The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG), electronic diary (PROCEDURE), voice acoustics (PROCEDURE).

Who is sponsoring clinical trial NCT00406952?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00406952's enrollment target sits among peer trials

165 626th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00406952, the US trial registry maintained by the National Library of Medicine. NCT00406952 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.